Urs Beat Hagemann

Title: Urs Beat Hagemann: Innovator in Complement Activation Inhibition

Introduction

Urs Beat Hagemann is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of biotechnology, particularly in the area of complement activation inhibition. With a total of nine patents to his name, Hagemann's work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Hagemann's latest patents focus on compositions for inhibiting MASP-2 dependent complement activation. The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation. This innovative approach aims to provide new avenues for treatment in conditions where complement activation plays a detrimental role.

Career Highlights

Throughout his career, Hagemann has worked with prominent organizations, including Omeros Corporation and Cancer Research Technology Limited. His experience in these companies has allowed him to develop and refine his inventions, contributing to advancements in medical science.

Collaborations

Hagemann has collaborated with notable professionals in his field, including Herald Reiersen and Thomas Dudler. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Urs Beat Hagemann is a distinguished inventor whose work in complement activation inhibition holds promise for future therapeutic developments. His contributions to biotechnology and collaboration with industry professionals underscore the importance of innovation in addressing complex medical challenges.